Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects. // Clinical Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S000991202600113X?dgcid=rss_sd_all
Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects. Clinical Medicine. https://www.sciencedirect.com/science/article/pii/S000991202600113X?dgcid=rss_sd_all
“Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects.” Clinical Medicine.
@article{article4752,
title = {Non-steroidal anti-inflammatory drugs and CYP2C9 – Impacts of genetics and phenoconversion on the risk of adverse effects},
journal = {Clinical Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S000991202600113X?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Journal of Taibah University Medical Sciences, Volume 21, Issue 6 Author(s): Mohammed Shehab, Abdulwahab AlSayegh, Hala AlOmar, Sharifa Al-Fajri, Ali H. Ziyab
Publication date: December 2026 Source: Journal of Taibah University Medical Sciences, Volume 21, Issue 6 Author(s): Mohanad Odeh, Ahmad Shadfan, Dani ZaidKaylani, Jude Arrabi, Nour A. Elsahoryi
Publication date: December 2026 Source: Journal of Taibah University Medical Sciences, Volume 21, Issue 6 Author(s): Ari Triwardhani, Nurul A.R. Putranti, Rizki Y. Rahmah, Nabila Z. Sannidhya, Ijma G. Putri, I Gusti Aju Wahju Ardani,...
Publication date: December 2026 Source: Journal of Taibah University Medical Sciences, Volume 21, Issue 6 Author(s): Mohammad Al-Harthy, Khalid Aljohani